Medication Management for Headache in Dengue Patients

Treatment and Monitoring

• The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, advises against the use of NSAIDs as first-line therapy in dengue patients due to the potential risk of bleeding complications in patients who may develop thrombocytopenia 1
• The American Academy of Family Physicians recommends adjunctive therapy with metoclopramide 10 mg orally for severe headaches unresponsive to acetaminophen, administered 20-30 minutes before or with acetaminophen 2
• The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, suggests non-pharmacological approaches, including adequate hydration, rest in a quiet and dark environment, and cool compresses to the forehead, for managing headache in dengue patients 1
• The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, recommends monitoring platelet counts and liver function tests regularly while treating dengue patients with any medication 1
• The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, advises watching for warning signs of severe dengue, including severe abdominal pain, persistent vomiting, mucosal bleeding, lethargy, or liver enlargement 1
• The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, recommends considering the possibility of central nervous system complications of dengue if headache worsens significantly or is accompanied by altered mental status, and performing appropriate neurological evaluation 1